Northwest Wealth Management’s First Trust Enhanced Short Maturity ETF FTSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,952
Closed -$236K 140
2021
Q4
$236K Hold
3,952
0.11% 113
2021
Q3
$237K Hold
3,952
0.12% 105
2021
Q2
$237K Sell
3,952
-2,695
-41% -$162K 0.13% 111
2021
Q1
$399K Sell
6,647
-185
-3% -$11.1K 0.25% 78
2020
Q4
$410K Sell
6,832
-477
-7% -$28.6K 0.28% 77
2020
Q3
$439K Buy
+7,309
New +$439K 0.36% 64
2019
Q4
Sell
-6,159
Closed -$370K 107
2019
Q3
$370K Hold
6,159
0.3% 81
2019
Q2
$370K Hold
6,159
0.3% 82
2019
Q1
$369K Sell
6,159
-100
-2% -$6K 0.28% 79
2018
Q4
$375K Sell
6,259
-482
-7% -$28.9K 0.32% 70
2018
Q3
$405K Sell
6,741
-1,450
-18% -$87K 0.3% 71
2018
Q2
$491K Sell
8,191
-4,202
-34% -$252K 0.37% 62
2018
Q1
$743K Buy
12,393
+3,569
+40% +$214K 0.55% 44
2017
Q4
$529K Buy
+8,824
New +$530K 0.43% 55

Other funds holding FTSM

Northwest Wealth Management's FTSM Position: Q1 2022 in Review

Northwest Wealth Management sold out of First Trust Enhanced Short Maturity ETF (FTSM) in Q1 2022, closing a stake of 3,952 shares — an estimated $236K sold.

Northwest Wealth Management first reported a position in FTSM in Q4 2017 and held it in 14 quarters. The position peaked at $743K in Q1 2018. 291 funds tracked by Wall St. Rank hold FTSM as of Q1 2022.

  • Northwest Wealth Management reported no remaining First Trust Enhanced Short Maturity ETF position as of Q1 2022 after selling out during the quarter.
  • Northwest Wealth Management sold 3,952 First Trust Enhanced Short Maturity ETF shares in Q1 2022, an estimated $236K.
  • Northwest Wealth Management first reported a position in First Trust Enhanced Short Maturity ETF in Q4 2017 and held it in 14 quarters.
  • Northwest Wealth Management's First Trust Enhanced Short Maturity ETF position peaked at $743K in Q1 2018.
  • 291 funds tracked by Wall St. Rank held First Trust Enhanced Short Maturity ETF as of Q1 2022.

Based on Northwest Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.